Taking people in Spanyolország1. fázis
A Study to Test How Safe, Effective and How the Body Responds to the Combination of Mosunetuzumab and Pirtobrutinib Together to Treat Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Key facts
- Where
- Barcelona, Madrid és Pamplona, SpanyolországSee the 3 sites
- Phase
- 1. fázis
Where in Spanyolország
- Hospital Universitari Vall d'HebronBarcelona, SpanyolországTaking people
- Clinica Universidad de NavarraMadrid, SpanyolországTaking people
- Clínica Universidad de navarraPamplona, SpanyolországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F. Hoffmann-La Roche AG
- Trial code
- EU 2024-514152-32-00
- Record updated
- 2026. július 13.